Rare diseases
Investigational molecules
Locations
Back to Greece260 clinical trials in Patras, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
GreeceStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
GreeceComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GreeceGreeceComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
GreeceA study comparing Rinatabart Sesutecan to other treatments in patients with endometrial cancer who have previously received platinum-based chemotherapy and PD-L1 therapy
GreeceA study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
GreeceA study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection
GreeceA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
GreeceA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
GreeceA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
GreeceTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.
Studies are exploring both long-term safety and immediate efficacy of new treatment options.
Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.
Focus on improving patient outcomes through targeted and combination therapies.
Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.
Studies are examining both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
